| 000 | 01582 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515193651.0 | ||
| 264 | 0 | _c20100203 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2009.10.105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSabarth, Nicolas | |
| 245 | 0 | 0 |
_aComparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. _h[electronic resource] |
| 260 |
_bVaccine _cJan 2010 |
||
| 300 |
_a650-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aCross Reactions |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunization, Secondary _xmethods |
| 650 | 0 | 4 |
_aInfluenza A Virus, H5N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xprevention & control |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 700 | 1 | _aHoward, M Keith | |
| 700 | 1 | _aSavidis-Dacho, Helga | |
| 700 | 1 | _avan Maurik, André | |
| 700 | 1 | _aBarrett, P Noel | |
| 700 | 1 | _aKistner, Otfried | |
| 773 | 0 |
_tVaccine _gvol. 28 _gno. 3 _gp. 650-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2009.10.105 _zAvailable from publisher's website |
| 999 |
_c19284153 _d19284153 |
||